10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2017 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 5,421 | 4,237 |
| Marketable securities, current | 1,391 | 2,113 |
| Receivables | 6,300 | 5,543 |
| Inventories | 1,166 | 1,241 |
| Prepaid expenses and other | 576 | 570 |
| Total Current Assets | 14,854 | 13,704 |
| Property, plant and equipment | 5,001 | 4,980 |
| Goodwill | 6,863 | 6,875 |
| Other intangible assets | 1,210 | 1,385 |
| Deferred income taxes | 1,610 | 2,996 |
| Marketable securities, noncurrent | 2,480 | 2,719 |
| Other assets | 1,533 | 1,048 |
| Total Assets | 33,551 | 33,707 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term debt obligations | 987 | 992 |
| Accounts payable | 2,248 | 1,664 |
| Accrued liabilities | 6,014 | 5,271 |
| Deferred income, current | 83 | 762 |
| Income taxes payable, current | 231 | 152 |
| Total Current Liabilities | 9,563 | 8,841 |
| Deferred income, noncurrent | 454 | 547 |
| Income taxes payable, noncurrent | 3,548 | 973 |
| Pension and other liabilities | 1,164 | 1,283 |
| Long-term debt | 6,975 | 5,716 |
| Total Liabilities | 21,704 | 17,360 |
| Commitments and contingencies | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,070 in 2017 and 4,129 in 2016, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2017 and 2016 | 221 | 221 |
| Capital in excess of par value of stock | 1,898 | 1,725 |
| Accumulated other comprehensive loss | (2,289) | (2,503) |
| Retained earnings | 31,160 | 33,513 |
| Less cost of treasury stock - 575 million common shares in 2017 and 536 million in 2016 | (19,249) | (16,779) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 11,741 | 16,177 |
| Noncontrolling interest | 106 | 170 |
| Total Equity | 11,847 | 16,347 |
| Total Liabilities and Equity | 33,551 | 33,707 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |